Related Experiment Video
Updated: Sep 14, 2025

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients
Published on: March 29, 2022
Changes in accommodation and vergence parameters with topical use of 0.025% and 0.05% atropine in myopes aged between
Edson Dos Santos-Neto1, Daniel Oliveira Dantas2, Dillan Cunha Amaral3
1Department of Ophthalmology and Otorhinolaryngology, Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil.
Objective:
To evaluate the vergence and accommodation parameters of myopic children in the use of 0.025% and 0.05% atropine.
Methods:
In total, 34 schoolchildren aged between 7 and 17 years were randomly divided into 2 groups: atropine 0.025% (n = 18) and atropine 0.05% (n = 16). The authors evaluated the parameters of accommodation and vergence before (baseline) and after the instillation of 1 drop of medication for 14 nights, on the 15th day in the morning. The accommodative parameters were near point of accommodation (NPA), accommodation amplitude (AA), negative relative accommodation (NRA), positive relative accommodation (PRA), accommodative facility (AF), accommodative lag (AL), and pupillary diameter. The vergence parameters were near point of convergence (NPC), accommodative convergence/accommodation (AC/A) ratio, positive fusional vergence (PFV), and negative fusional vergence (NFV).
Results:
There were significant changes in the accommodative parameters: NPA from 5.85 ± 1.75 cm to 11.33 ± 4.58 cm (atropine 0.025%) and from 5.23 ± 1.31 to 14.94 ± 9.36 cm (atropine 0.05%); reduction of AA from 18.58 ± 5.62D to 11.07 ± 6.99D (atropine 0.025%) and from 20.23 ± 5.11 to 9.40 ± 5.32D (atropine 0.05%); reduction of PRA in absolute terms (modulus) from -3.72 ± 1.90 to -2.12 ± 0.79 and from -4.31 ± 1.88 to -2.02 ± 0.98 (atropine 0.05%); reduction of AF from 10.56 ± 3.50 cpm to 5.00 ± 5.59 cpm (atropine 0.025%) and from 11.56 ± 2.16 to 1.94 ± 3.82 cpm (atropine 0.05%); and increase in pupillary diameter from 4.16 ± 0.90 mm to 5.44 ± 0.97 mm (atropine 0.025%) and from 4.04 ± 0.50 mm to 6.69 ± 0.62 mm (atropine 0.05%). In the vergence parameters, only the Near PFV with 0.025% atropine and changes in Far PFV with both 0.025% and 0.05% atropine showed significant differences compared to baseline.
Conclusions:
Under the conditions of this study, the use of atropine at concentrations of 0.025% and 0.05% induced significant disturbances in the accommodative system, causing visual discomfort.
More Related Videos
06:19Comparison of Three Clinical Stereoscopic Methods for Measuring Binocular Visual Function During Amblyopic Treatment in Unilateral Amblyopia
Published on: September 27, 2024
08:27Quantification of Oculomotor Responses and Accommodation Through Instrumentation and Analysis Toolboxes
Published on: March 3, 2023
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Cholinergic Antagonists: Pharmacokinetics